|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,078.70 INR | -0.86% |
|
-2.43% | +17.97% |
| 06-10 | Zydus Lifesciences Unit Secures Reduction in GST Tax Demands | MT |
| 06-03 | Zydus Lifesciences Receives USFDA Warning Letter for Baddi Facility | MT |
| Market Cap | 1,095B 11.59B 9.99B 9.19B 8.62B 16.19B 16.36B 109B 42.44B 536B 43.48B 42.55B 1,855B | P/E Ratio 2026 |
17.4x | P/E Ratio 2027 * | 25.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1,089B 11.52B 9.93B 9.14B 8.57B 16.1B 16.26B 108B 42.19B 533B 43.22B 42.31B 1,845B | EV / Sales 2026 |
3.61x | EV / Sales 2027 * | 3.82x |
| Free-Float |
24.83% | Yield 2026 |
0.11% | Yield 2027 * | 0.61% |
Last Transcript: Zydus Lifesciences Limited
| 1 day | -0.86% | ||
| 1 week | -2.43% | ||
| Current month | +0.09% | ||
| 1 month | +8.84% | ||
| 3 months | +21.63% | ||
| 6 months | +17.97% | ||
| Current year | +17.97% |
| 1 week | 1,072.4 |  | 1,119.8 |
| 1 month | 987.85 | | 1,119.8 |
| Current year | 835.5 | | 1,119.8 |
| 1 year | 835.5 | | 1,119.8 |
| 3 years | 547.9 | | 1,324.3 |
| 5 years | 319 | | 1,324.3 |
| 10 years | 202 | | 1,324.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 46 | 2009-11-26 | |
| Director of Finance/CFO | 56 | 2025-08-31 | |
| Director of Finance/CFO | 65 | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 74 | 2018-12-05 | |
| Chairman | 73 | 2011-10-04 | |
| Director/Board Member | 71 | 1997-07-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.86% | -2.43% | +10.70% | +95.75% | 11.59B | |
| -0.29% | +1.22% | +6.85% | +81.52% | 45.85B | |
| +1.27% | +0.83% | +43.63% | +86.33% | 33.63B | |
| -0.59% | -0.24% | -10.07% | +36.49% | 11.81B | |
| +0.19% | +3.12% | +40.43% | +132.60% | 9.28B | |
| -0.99% | +1.18% | +19.32% | +42.62% | 7.33B | |
| -0.26% | +2.06% | +44.67% | -18.15% | 6.65B | |
| +0.00% | -2.39% | +28.12% | +235.70% | 6.44B | |
| +0.06% | +0.32% | -43.02% | -3.78% | 5.16B | |
| +0.83% | +2.07% | +18.53% | +109.66% | 4.04B | |
| Average | -0.08% | +0.27% | +15.92% | +79.87% | 14.18B | |
| Weighted average by Cap. | +0.05% | -0.19% | +18.58% | +81.44% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 261B 2.76B 2.38B 2.19B 2.06B 3.86B 3.9B 25.93B 10.13B 128B 10.37B 10.15B 443B | 310B 3.28B 2.83B 2.6B 2.44B 4.58B 4.63B 30.76B 12.01B 152B 12.31B 12.05B 525B |
| Net income | 46.58B 493M 425M 391M 367M 689M 696M 4.62B 1.81B 22.81B 1.85B 1.81B 78.94B | 42.46B 449M 387M 356M 334M 628M 634M 4.21B 1.65B 20.79B 1.69B 1.65B 71.95B |
| Net Debt | -6.32B -66.92M -57.68M -53.08M -49.8M -93.54M -94.48M -628M -245M -3.1B -251M -246M -10.72B | 88.69B 938M 809M 744M 698M 1.31B 1.32B 8.8B 3.44B 43.43B 3.52B 3.45B 150B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-16 | 1,078.70 ₹ | -0.86% | 1,049,320 |
| 26-06-15 | 1,088.10 ₹ | -1.50% | 1,138,903 |
| 26-06-12 | 1,104.70 ₹ | -0.11% | 872,151 |
| 26-06-11 | 1,105.90 ₹ | +0.69% | 728,343 |
| 26-06-10 | 1,098.30 ₹ | -0.66% | 598,159 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ZYDUSLIFE Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition